Dr. Reddy’s Laboratories has announced a strategic collaboration with Shanghai Henlius Biotech, Inc. (2696.HK) to commercialize HLX15, a biosimilar candidate to Darzalex® & Darzalex Faspro® (daratumumab), in the United States and Europe. This move strengthens Dr. Reddy’s presence in the critical oncology space and promises to offer more affordable treatment options to patients.
Under the terms of the agreement, Dr. Reddy’s will have exclusive rights to commercialize both subcutaneous and intravenous formulations of HLX15 in the US and European markets. Henlius will handle the development, manufacturing, and supply of the biosimilar. The deal involves an upfront payment of $33 million to Henlius, with potential milestone payments totaling up to $131.6 million, plus royalties on net sales.
Dr. Reddy’s CEO, Erez Israeli, expressed enthusiasm for the partnership, stating that it will help make this daratumumab biosimilar available to patients in the U.S. and Europe.
Advertisement
HLX15 is a fully human anti-CD38 monoclonal antibody being developed as a biosimilar to treat multiple myeloma. Its development follows rigorous biosimilar guidelines set by regulatory bodies like the NMPA, EMA, and USFDA. Clinical studies have shown HLX15 to have comparable pharmacokinetic characteristics, safety, and immunogenicity profiles to the reference drug.
Henlius’ CEO, Dr. Jason Zhu, highlighted the collaboration with Dr. Reddy’s as a vital step in addressing global health needs and enhancing access to advanced biologics.
Impact on Dr. Reddy’s Stock:
Analysts are viewing this collaboration positively, citing the potential for Dr. Reddy’s to capture a significant share of the daratumumab market in the US and Europe. The addition of HLX15 to Dr. Reddy’s biosimilar pipeline is expected to contribute to long-term growth and profitability. Investors will be closely watching the progress of HLX15 through regulatory approvals and eventual commercialization.
Disclaimer: The information provided is for educational purposes only and does not constitute financial advice. We are not registered financial advisors. Please conduct your own research and consult a qualified advisor before making investment decisions. Any investment decisions you make based on this information are solely at your own risk.
Also read: JSW Energy Subsidiary Signs 180 MW Wind Power Deal with Amazon
Published on: February 8, 2025 at 8.26PM GMT.
Aero India 2025:
Asia’s biggest air show, Aero India 2025, inaugurated at Yelahanka Air Force Station in Bengaluru. The main attractions include some of the advanced fifth-generation stealth fighters, which will be flown here for the first time outside Russia, namely Sukhoi Su-57, and from the U.S. Air Force, F-35 Lightning II. Defence Minister Rajnath Singh will open the ‘India Pavilion’ at the show.
As stated in Bhagavad Gita : (Bhagavad Gita 15.15)
सर्वस्य चाहं हृदि सन्निविष्टो मत्तः स्मृतिरज्ञानमपोहनं च।
I am seated in everyone’s heart; from Me come remembrance, knowledge, and forgetfulness.
10th February is celebrated as International Cribbage Day!
